Joseph M. Cahalan is the CEO of Concern Worldwide U.S., the affiliate of Concern Worldwide, a nongovernmental, international, humanitarian organization dedicated to the reduction of suffering and elimination of extreme poverty in the world's poorest countries. He came to Concern after more than 40 years at the Xerox Corp., where he served as vice president of communications and social responsibility and as president of the Xerox Foundation.

Dr. Joseph de Graft-Johnson is a public health physician and has worked as a medical doctor and in international public health for over 30 years in Africa, the Caribbean, and Asia. de Graft-Johnson received his medical degree from School of Medical Sciences, Kumasi, Ghana and his public health degrees, MPH and DrPH, from the University of North Carolina at Chapel Hill. He worked with the Ghana Ministry of Health and Family Health International before joining Save the Children as a health program manager in Malawi in 1997 and has held various positions since. The most recent being the senior director of the maternal and reproductive health team. He has spent over 20 years contributing to the advancement of newborn health programming in low- and middle-income countries.

Joseph Dieleman, Ph.D., is assistant professor at the Institute for Health Metrics and Evaluation at the University of Washington. In this role, he leads the financial resources for health research team, which focuses on domestic and international research tracking development assistance for health, health spending by disease, and government health expenditure. Joe studied at Calvin College in Grand Rapids, Michigan, earning his undergraduate degree in economics, and at the University of Washington, where he received his Ph.D. in Economics.

Joseph Kraus is senior policy manager for transparency and accountability at the ONE Campaign, an international organization working to end extreme poverty in Africa. Previously, he was the program and development director at EG Justice. He holds a doctorate in political science with a focus on Africa.

Joseph Lemoine is the deputy director of the Atlantic Council’s Freedom and Prosperity Center. Previously, he was a private sector specialist at the World Bank. He advised governments on policy reforms that help boost entrepreneurship and shared prosperity, primarily in Francophone Africa and the Middle East.

Joseph Marks is a Devex correspondent based in Washington, D.C., where he covers stories related to international development, economics, diplomacy and foreign policy. He has written about the Israeli-Palestinian conflict, homeland security, technology, global Internet freedom, trade and U.S. law.

Dr. Joseph Muscat is prime minister of Malta, one of the fastest growing economies in Europe. He led the Labour Party to a landslide win in March 2013 at the age of 39 and secured another landslide victory in June 2017. He is an economist and journalist and a former member of the European Parliament. He has been leader of the Labour Party for 10 years.

Joseph Nhan-O’Reilly is the head of education policy and advocacy at Save the Children. He was elected to the newly constituted Global Partnership for Education Board in 2010 and again in 2012. From 2014 to 2017, Joseph was the inaugural chair of the board’s Strategy and Policy Committee. He was a member of the group that designed Education Cannot Wait and serves on its Executive Committee and is the Chair of the Global Book Alliance. These are his personal views and not the official position of any of the above agencies.

Josette Gbemudu is the executive director of health equity for MSD. Josette leads MSD’s U.S. health equity division, helping to ensure a focus on health equity is embedded across the organization. Collaborating with key business functions, she develops and leads the execution of a unified health equity strategy. With more than 10 years of experience at MSD, Josette has led private sector contracting in the company’s U.S. vaccines organization, scientific strategy for its anesthesia and surgery marketing franchise, and played an instrumental role in building its U.S. commercial strategy.